Cargando…
Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials
BACKGROUND: Multiple oral chemotherapeutic agents for metastatic hormone-sensitive prostate cancer (mHSPC) have been developed for conjugated use with conventional androgen deprivation therapy (ADT). Several randomized controlled trials (RCTs) report significant benefits in mHSPC patients. Therefore...
Autores principales: | Lee, Yong Seong, Kim, Seong Hwan, Tae, Jong Hyun, Chang, In Ho, Kim, Tae-Hyoung, Myung, Soon Chul, Kim, Myoungsuk, Nguyen, Tuan Thanh, Choi, Joongwon, Kim, Jung Hoon, Kim, Jin Wook, Choi, Se Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513908/ https://www.ncbi.nlm.nih.gov/pubmed/37745904 http://dx.doi.org/10.1016/j.prnil.2023.06.003 |
Ejemplares similares
-
Changes in patient perceptions regarding ChatGPT-written explanations on lifestyle modifications for preventing urolithiasis recurrence
por: Kim, Seong Hwan, et al.
Publicado: (2023) -
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
por: Lee, Yong Seong, et al.
Publicado: (2023) -
Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study
por: Tae, Jong Hyun, et al.
Publicado: (2022) -
Urinary tract infection after radiation therapy or radical prostatectomy on the prognosis of patients with prostate cancer: a population-based study
por: Hyun, Jihye, et al.
Publicado: (2023) -
Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials
por: Choi, Se Young, et al.
Publicado: (2022)